Protocol for the neonatal intracerebroventricular delivery of adeno-associated viral vectors for brain restoration of MECP2 for Rett syndrome

STAR Protoc. 2024 Dec 20;5(4):103344. doi: 10.1016/j.xpro.2024.103344. Epub 2024 Sep 25.

Abstract

Here, we present a protocol for neonatal intracerebroventricular (ICV) delivery of adeno-associated viral vectors (AAVs), achieving gene therapy for a Rett syndrome mouse model. We describe steps for preparing mouse lines, replacing foster mothers, sex typing, and genotyping. We then detail procedures for ICV delivery and validation through immunofluorescent and immunoblot techniques. This protocol is also applicable to preclinical gene therapy research that targets the neonatal mouse brain for other neurodevelopmental disorders. For complete details on the use and execution of this protocol, please refer to Yang et al.1.

Keywords: clinical protocol; model organisms; neuroscience.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn*
  • Brain* / metabolism
  • Dependovirus* / genetics
  • Disease Models, Animal*
  • Female
  • Gene Transfer Techniques
  • Genetic Therapy* / methods
  • Genetic Vectors* / administration & dosage
  • Genetic Vectors* / genetics
  • Injections, Intraventricular
  • Male
  • Methyl-CpG-Binding Protein 2* / genetics
  • Methyl-CpG-Binding Protein 2* / metabolism
  • Mice
  • Rett Syndrome* / genetics
  • Rett Syndrome* / therapy

Substances

  • Methyl-CpG-Binding Protein 2
  • Mecp2 protein, mouse